These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T; Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082 [TBL] [Abstract][Full Text] [Related]
23. Glargine and lispro: two cases of mistaken identity. Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523 [No Abstract] [Full Text] [Related]
24. Impact of insulin delivery devices in diabetes care. Garg SK Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296 [No Abstract] [Full Text] [Related]
25. Designer insulins: moving closer to convenient and physiological replacement of insulin. Boyages SC Med J Aust; 1999 Apr; 170(8):349-50. PubMed ID: 10327943 [No Abstract] [Full Text] [Related]
26. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related]
27. A case of suppurative granuloma induced by insulin injection. Tanizaki H; Matsumura Y; Tokura Y; Miyachi Y; Kabashima K Acta Derm Venereol; 2010 Sep; 90(5):540-1. PubMed ID: 20814643 [No Abstract] [Full Text] [Related]
28. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Gupta J; Felner EI; Prausnitz MR Diabetes Technol Ther; 2011 Apr; 13(4):451-6. PubMed ID: 21355717 [TBL] [Abstract][Full Text] [Related]
29. Metabolic decompensation in pump users due to lispro insulin precipitation. Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980 [No Abstract] [Full Text] [Related]
30. On calculating treatment satisfaction. Bradley C Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762 [No Abstract] [Full Text] [Related]
31. Possible problem with Optipen Pro-1: should diabetic patients continue to use this product? Goksen D; Darcan S; Buyukinan M; Kurt E Diabetes Care; 2006 Jul; 29(7):1710-1. PubMed ID: 16801608 [No Abstract] [Full Text] [Related]
32. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump. Catargi B; Breilh D; Roger P; Tabarin A Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895 [TBL] [Abstract][Full Text] [Related]
33. Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes. Burge MR; Carey JD Diabetes Care; 2004 Jan; 27(1):275-6. PubMed ID: 14694005 [No Abstract] [Full Text] [Related]
34. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus. Szypowska A; Skórka A; Pańkowska E Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499 [TBL] [Abstract][Full Text] [Related]
35. Lispro, a rapid-onset insulin. Med Lett Drugs Ther; 1996 Oct; 38(986):97-8. PubMed ID: 8906134 [No Abstract] [Full Text] [Related]
36. [Use of insulin pumps in Denmark]. Nørgaard K Ugeskr Laeger; 2003 Jun; 165(23):2380-2. PubMed ID: 12840995 [No Abstract] [Full Text] [Related]
37. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications? Ampudia-Blasco FJ; Hasbum B; Carmena R Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070 [No Abstract] [Full Text] [Related]
38. Using insulin pump therapy to achieve normoglycemia. Van Buren PD JAAPA; 2003 Jul; 16(7):33-6. PubMed ID: 14968497 [No Abstract] [Full Text] [Related]